Company Filing History:
2 out of 2 
2 out of 832,843 Years Active: 2023
Title: Zishan Zhou: Innovator in Biotechnology
Introduction
Zishan Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative medical solutions. With a total of two patents to his name, Zhou is recognized for his groundbreaking work in cancer treatment and vaccine development.
Latest Patents
Zhou's latest patents include the LRFFT2 cell and a coronavirus-targeting universal dendritic cell (DC) vaccine. The LRFFT2 cell patent involves using human peripheral blood for circulating tumor DNA (ctDNA) sequencing or tumor tissues for whole exome sequencing. This process screens for mutation sites to perform antigen epitope prediction and synthesizes an expression gene sequence of mutant peptides. Additionally, it constructs a lentiviral vector to transfect antigen-presenting cells, transforming common T cells into RFF cells. The second patent focuses on a method for preparing a coronavirus-targeting universal DC cell vaccine. This method ligates a fusion gene, including an HLA gene and a coronavirus antigen gene, onto an expression vector, which is then transferred into antigen-presenting cells to create an effective vaccine.
Career Highlights
Zishan Zhou has worked with Beijing Dcty Biotech Co., Ltd., where he has contributed to various innovative projects. His expertise in biotechnology has positioned him as a key player in the development of advanced medical technologies.
Collaborations
Zhou has collaborated with notable professionals in his field, including Shunchang Jiao and Rong Zhang. These collaborations have further enhanced his research and development efforts.
Conclusion
Zishan Zhou is a distinguished inventor whose work in biotechnology has the potential to revolutionize cancer treatment and vaccine development. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.